NDC11 27808024901
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 27808-0249-01 | 27808-0249 |
| 27808-0249-1 | 27808-0249 |
| 27808-249-01 | 27808-249 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deflazacort Oral Suspension | DEFLAZACORT ORAL | Cranbury Pharmaceuticals, LLC | 881785a5-41b4-4679-a29b-5d77ca51ca60 | 2026-06-03 | Warnings, Adverse reactions | 27808-249-01 27808-249 27808024901 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.